Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05181709 |
|---|---|
| Brief Title: | A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. |
| First Submitted : | January 4, 2022 |
| First Submitted that Met QC Criteria : | January 4, 2022 |
| First Posted : | January 6, 2022 |
| Last Update Submitted that Met QC Criteria : | April 24, 2024 |
| Last Update Posted : | April 26, 2024 |